Strategic Partnership Natus Medical Incorporated has selected Persyst for integrating AI-powered seizure detection algorithms, indicating a strong potential for collaboration in OEM partnerships and co-developed solutions.

Expanded Market Persyst serves a global EEG market with applications in continuous, long-term, and ambulatory monitoring, suggesting multiple entry points for upsell of advanced analytics, cloud capabilities, and regulatory-ready solutions.

Regulatory Readiness Current FDA 510(k) review for AI seizure detection indicates ongoing regulatory activity; prioritize sales discussions around regulatory support, documentation, and risk management offerings to accelerate adoption.

Financial Stability With annual revenue in the 10 to 25 million range and a focused software portfolio, Persyst presents a scalable customer for tiered pricing, enterprise licenses, and value-based bundles for hospitals and manufacturers.

OEM & Integration Persyst is the leading supplier of seizure and spike detection software to EEG manufacturers, highlighting opportunities to propose seamless integration kits, deployment services, and joint go-to-market programs with device partners.